...
首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
【24h】

Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.

机译:小儿急性淋巴细胞白血病口腔粘膜炎与大剂量甲氨蝶呤治疗的关系。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Oral mucositis is a major toxicity in the high-dose methotrexate (HD-MTX) treatment for children with acute lymphoblastic leukemia (ALL). The first aim of this study was to evaluate the relationship between the MTX serum concentration and occurrence of oral mucositis in pediatric ALL patients. The second aim was to clarify the relationship between MTX exposure and epidermal keratinocyte cell injury using an in vitro study. METHODS: 49 patients were treated according to the Japan Association of Childhood Leukemia Study (JACLS) ALL-HR02 protocol. This protocol involves HD-MTX treatment (3 g/m2 for 24-h i.v. infusion). The MTX serum concentrations were measured by a fluorescence polarization immunoassay. The relationship between oral mucositis and MTX serum concentrations 48 and 72 h after administration was determined. The cell toxicity of MTX for human epidermal keratinocytes was analyzed by using a cell viability assay (WST-1 assay). In addition, pharmacokinetic evaluation for clearance, AUCextrapolated from 48 h to infinity (AUC48h-inf) and elimination half-life (t1/2b) were done using the 1-compartmental models. RESULTS: Oral mucositis occurred in 24 patients (49.0%), in whom 20 patients (83.3% in oral mucositis group) showed WHO severity Grade 1 or 2. Only 4 patients (16.7% in oral mucositis group) showed Grade 3 severity. 22 patients (44.9%) had oral mucositis in the group with a concentration under 10-6 M 48 h after MTX administration. There was no significant deference among the cell viabilities in the concentrations of 10-6 M, 10-5 M and 10-4 M 48 h after the MTX exposure. However, the cell viability obtained 24 h after the MTX exposure was significantly different from the respective cell viability 48, 72 and 96 h after the MTX exposure. In the group with oral mucositis, the clearance decreased significantly (p = 0.042), and the t1/2b (p = 0.025) and AUC48h- yen (p = 0.025) increased significantly compared with the non-symptom group. CONCLUSIONS: It seems that there is no significant relationship between the serum MTX concentration and oral mucositis. This in vitro study has demonstrated that the cell injury was related to the duration of MTX exposure rather than a high MTX concentration.
机译:目的:口腔粘膜炎是大剂量甲氨蝶呤(HD-MTX)治疗急性淋巴细胞白血病(ALL)儿童的主要毒性。这项研究的第一个目的是评估小儿ALL患者MTX血清浓度与口腔粘膜炎发生之间的关系。第二个目的是通过一项体外研究来阐明MTX暴露与表皮角质形成细胞损伤之间的关系。方法:根据日本儿童白血病协会(JACLS)ALL-HR02协议对49例患者进行了治疗。该方案涉及HD-MTX处理(24小时静脉输注3 g / m2)。通过荧光偏振免疫测定法测量MTX血清浓度。确定在给药后48和72小时口腔粘膜炎与MTX血清浓度之间的关系。通过使用细胞活力测定法(WST-1测定法)分析了MTX对人表皮角质形成细胞的细胞毒性。此外,使用1-格模型对清除率,从48小时外推到无限远的AUC(AUC48h-inf)和消除半衰期(t1 / 2b)进行药代动力学评估。结果:口腔粘膜炎发生24例(49.0%),其中20例(口腔粘膜炎组为83.3%)显示WHO严重性为1或2级。仅4例患者(口腔粘膜炎组为16.7%)显示3级严重性。在MTX给药后48小时,该组中22例(44.9%)患有口腔粘膜炎,其浓度低于10-6M。在MTX暴露48小时后,在10-6 M,10-5 M和10-4 M的浓度下,细胞活力之间无显着差异。然而,MTX暴露后24小时获得的细胞生存力与MTX暴露后48、72和96小时各自的细胞生存力显着不同。与无症状组相比,口腔粘膜炎组的清除率显着降低(p = 0.042),t1 / 2b(p = 0.025)和AUC48h-日元(p = 0.025)显着增加。结论:血清MTX浓度与口腔粘膜炎之间似乎没有显着关系。这项体外研究表明,细胞损伤与MTX暴露持续时间有关,而不是与高MTX浓度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号